Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2015 2
2016 1
2017 6
2018 8
2019 3
2020 1
2021 3
2022 2
2023 4
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Lancet Diabetes Endocrinol. 2021 Dec;9(12):837-846. doi: 10.1016/S2213-8587(21)00263-1. Epub 2021 Oct 28. Lancet Diabetes Endocrinol. 2021. Retraction in: Lancet Diabetes Endocrinol. 2024 Jan;12(1):8. doi: 10.1016/S2213-8587(23)00364-9 Retracted and republished in: Lancet Diabetes Endocrinol. 2024 Jan;12(1):e2-e11. doi: 10.1016/S2213-8587(23)00287-5 PMID: 34717822 Free PMC article. Retracted. Retracted and republished.
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration. Lancet Diabetes Endocrinol. 2024 Jan;12(1):e2-e11. doi: 10.1016/S2213-8587(23)00287-5. Epub 2023 Dec 1. Lancet Diabetes Endocrinol. 2024. PMID: 38048800 Free PMC article.
Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes.
Elías-López D, Wadström BN, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG. Elías-López D, et al. Among authors: kobylecki cj. Curr Diab Rep. 2024 Dec;24(12):290-300. doi: 10.1007/s11892-024-01555-1. Epub 2024 Oct 2. Curr Diab Rep. 2024. PMID: 39356419 Review.
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Burgess S, Ference BA, Staley JR, Freitag DF, Mason AM, Nielsen SF, Willeit P, Young R, Surendran P, Karthikeyan S, Bolton TR, Peters JE, Kamstrup PR, Tybjærg-Hansen A, Benn M, Langsted A, Schnohr P, Vedel-Krogh S, Kobylecki CJ, Ford I, Packard C, Trompet S, Jukema JW, Sattar N, Di Angelantonio E, Saleheen D, Howson JMM, Nordestgaard BG, Butterworth AS, Danesh J; European Prospective Investigation Into Cancer and Nutrition–Cardiovascular Disease (EPIC-CVD) Consortium. Burgess S, et al. Among authors: kobylecki cj. JAMA Cardiol. 2018 Jul 1;3(7):619-627. doi: 10.1001/jamacardio.2018.1470. JAMA Cardiol. 2018. PMID: 29926099 Free PMC article.
Response.
Kobylecki CJ, Wium-Andersen MK, Afzal S, Nordestgaard BG. Kobylecki CJ, et al. Acta Psychiatr Scand. 2018 Jan;137(1):80. doi: 10.1111/acps.12831. Epub 2017 Nov 1. Acta Psychiatr Scand. 2018. PMID: 29090736 No abstract available.
32 results